CD8A and telomere syndrome: In some non-STS tumors, TAMs are thought to inhibit the cytotoxic and chemotactic effects of CD8+ T cells [51], whereas in undifferentiated sarcomas, the CD8+ and TAM counts may correlate positively [52].